Contents

Welcome to ICoP India 2026 — Where Science Meets Strategy

We are delighted to welcome you to the International Conference on Pharmacometrics (ICoP India 2026) — the second annual conference of the Society of Pharmacometrics and Health Analytics (formerly PAGIN).

Organized by the Centre for Pharmacometrics, Manipal College of Pharmaceutical Sciences (MCOPS), MAHE, and proudly supported by the International Society of Pharmacometrics (ISoP), this conference brings together a vibrant and growing community advancing quantitative approaches in drug development.

Theme: Quantitative Approaches in Drug Development — A Path Forward
This year’s theme reflects our shared commitment to model-informed drug development (MIDD) and the expanding role of pharmacometrics and health analytics in driving better therapeutic decisions.

ICoP India 2026 will serve as a dynamic platform for researchers, clinicians, regulators, and industry leaders to exchange ideas, present cutting-edge science, and foster meaningful collaborations.

A special call goes out to the Indian pharmacometrics diaspora across the globe — your insights and leadership are key as we work together to elevate India’s presence in this evolving discipline.

Join us as we chart a collective path forward in quantitative drug development.

Important Dates

Grab your Early bird offer

Early Bird registration is open until December 20, 2025 | late registration runs from December 20, 2025 to January 20, 2026.

Event
Date
Pre-conference workshop
Wed, 28 Jan 2026
Conference
Thu, 29 Jan 2026 | Fri, 30 Jan 2026
Post-conference workshop
Sat, 31 Jan 2026
Abstract submission
4 Aug to 30 Nov 2025

Programme Schedule: Speakers & Topics

web 1
web 2

Register to Attend

Register to attend ICoP India 2026 and its satellite workshops. You may register for the main conference, pre-conference workshops, and post-conference workshops separately using the respective forms.

Main Conference (29–30 January 2026)

Includes access to all conference sessions, materials, and refreshments.

Category
Early Bird (Till Dec 30)
Late Registration (Dec 30 to Jan 20)
Students
₹ 6,000
₹ 7,000
Academicians
₹ 7,000
₹ 8,000
Industry Professionals
₹ 17,500
₹ 20,000
Category
Early Bird (Till Dec 30)
Late Registration (Dec 30 to Jan 20)
Students
$ 125
$ 150
Academicians
$ 150
$ 200
Industry Professionals
$ 300
$ 350

Opening Soon !!



Pre-Conference Workshops (28 January 2026)

Date: 28 Jan 2026 | Timing: Full Day

Presenters:

  • Sivacharan Kollipara, PhD
    Head, Biopharmaceutics, Global Clinical Management,
    Dr. Reddy’s Laboratories Ltd

  • Sheila Annie Peters, PhD
    Executive Director, Boehringer Ingelheim, Germany

  • Rajkumar Boddu, PhD
    Team Lead, Biopharmaceutics, Global Clinical Management,
    Dr. Reddy’s Laboratories Ltd

Workshop Description:

Over the past few years, physiologically based pharmacokinetics (PBPK) models have demonstrated their potential in predicting & circumventing complex drug-drug interaction (DDI) studies arising at systemic and absorption level. Apart from PBPK models, quantitative mechanistic static models (qMSM) can also be used to screen DDIs early in the development and to support internal decisions and regulatory submissions.

The aim of this 1-day workshop is to provide concepts of PBPK and MSM in predicting DDI’s for internal decision making and regulatory filings. Theoretical aspects coupled with case examples and hands on with PK SIM and Gastroplus will be covered with fundamentals of pharmacokinetic and biopharmaceutics aspects.

Category
Registration Fee (per participant)
Students/Trainees
₹ 1500
Academicians
₹ 2000
Industry Professionals
₹ 3000

Date: 28 Jan 2026 | Timing: Morning to Noon

Presenters:

  • Bhairav Paleja, PhD
    Principal Scientist, Vantage Research

  • Kannan Thiagarajan, PhD
    Principal Scientist, Vantage Research

  • Tanay Parab, Pharm.D
    Associate Scientist, Centre for Pharmacometrics,
    MCOPS, MAHE

  • TBA


Workshop Description:

This 3-hour tutorial introduces participants to systems thinking in pharmacology and demonstrates how quantitative models support decision making across efficacy and safety.

The session begins with a conceptual overview of model-informed pharmacology, followed by a structured walkthrough of an antibody drug conjugate (ADC) efficacy case study, illustrating how PK/PD and mechanistic insights guide dose and schedule selection. Participants will then engage in a guided hands-on PK/PD exercise, designed to build understanding of exposure-response relationships. The tutorial concludes with a mechanistic ADC-induced thrombocytopenia case study to highlight how systems models predict hematologic toxicity and inform therapeutic windows.

This session is tailored for pharmacology students, researchers, and industry professionals seeking a practical introduction to quantitative, model-enabled drug development.

Category
Registration Fee (per participant)
Students/Trainees
₹ 1000
Academicians
₹ 1500
Industry Professionals
₹ 2500

Date: 28 Jan 2026 | Timing: Morning to Noon

Presenters:

  • Smita Pattanaik, MD (Pharmacology), DNB (Pharmacology), DM (Clinical Pharmacology)
    Professor of Clinical Pharmacology,
    Post Graduate Institute of Medical Education and Research

  • Jeffrey Pradeep Raj, MD (Pharmacology), DM (Clinical Pharmacology)
    Associate Professor & Division Head, Division of Clinical Pharmacology, Kasturba Medical College, Manipal

  • Khushboo Bisht, MD, DM (Clinical Pharmacology), AFAMS
    Assistant Professor,
    All India Institute of Medical Sciences, Nagpur

  • Niveditha Gowda, MD (Pharmacology), DM Resident (Clinical Pharmacology)
    Post Graduate Institute of Medical Education and Research

Workshop Description:

Model-Informed Precision Dosing (MIPD) is rapidly reshaping clinical practice by enabling personalised, data-driven therapeutic decisions. Its growing adoption across Indian hospitals, academic medical centres, and specialty clinics highlights its role in optimising drug dosing using pharmacokinetic, pharmacodynamic, and patient-specific data.

This symposium aims to familiarise students, researchers, and clinicians with the clinical evidence base and foundational principles of MIPD, and its application in real-world patient care. Early sensitisation will equip learners to translate quantitative pharmacology into informed bedside decisions.

The programme will comprise 4–5 focused sessions across key therapeutic areas, integrating theory, clinical evidence, and practice. Live demonstrations of MIPD software platforms and web-based dashboards will showcase how model outputs guide individualised dosing, particularly for drugs with narrow therapeutic windows, high PK variability, or life-critical indications. Experienced clinicians will share practical insights, challenges, and best practices.

Key MIPD Drug Candidates Across Therapeutic Areas

  • Organ Transplantation: Tacrolimus, Mycophenolate
  • Oncology: Methotrexate, Busulfan, 5-Fluorouracil (5-FU)
  • Anti-infectives: Vancomycin, Linezolid, Meropenem
  • Psychiatry & CNS Disorders: Lithium, Clozapine, Valproate, Carbamazepine, Levetiracetam
Category
Registration Fee (per participant)
Students/Trainees
₹ 1000
Academicians
₹ 1500
Industry Professionals
₹ 2500

International delegates please contact organizers for registration: icop.india@sophas.net

Opening Soon !!



Post-Conference Workshops (31 January 2026)

Date: 30 Jan 2026 | Timing: Full Day

Presenters:

  • Martin Johnson, PhD
    Executive Director, Pharmacometrics, Allucent, UK

  • Jaya Shree Dilli Batcha, PhD
    Scientist, Centre for Pharmacometrics,
    MCOPS, MAHE

  • Harissh Chandrasekaran, Pharm.D
    Associate Scientist, Centre for Pharmacometrics,
    MCOPS, MAHE


Workshop Description:

This one-day, hands-on workshop introduces participants to modern and reproducible pharmacometric simulation workflows in R. Using the tidyverse and mrgsolve (or similar), the session connects key PK/PD concepts with practical model implementation, data handling, and visualisation.

Through short lectures, guided coding, and interactive discussions, participants will learn to:

  • Use the tidyverse for efficient data import, cleaning, summarisation, and plotting.

  • Build and simulate PK and PKPD models (e.g., 1-compartment, Emax, indirect-response).

  • Include inter-individual variability and residual error for population simulations.

  • Create fully reproducible workflows using R Markdown.

By the end of the day, attendees will be able to interpret model outputs, generate publication-ready plots, and perform basic design evaluations.

This workshop is ideal for Master’s/PhD students in pharmacometrics, clinical pharmacy, or related fields who know basic R but are new to model-based simulation. Participants will leave with open-source, practical skills to support Model-Informed Drug Development (MIDD) in both academic and industry settings.

Category
Registration Fee (per participant)
Students/Trainees
₹ 1500
Academicians
₹ 2000
Industry Professionals
₹ 3000

Date: 28 Jan 2026 | Timing: Full Day

Presenters:

  • Vijay Ivaturi, PhD
    Co-Founder & CEO, Pumas-AI Inc. Endowed Chair, Center for Pharmacometrics, Manipal. President, ISoP

  • Nikita Ramwani, M.Pharm
    Scientist, Pumas-AI Inc

  • Pavan R, Pharm.D
    Associate Scientist, Centre for Pharmacometrics,
    MCOPS, MAHE

  • Tanay Parab, Pharm.D
    Associate Scientist, Centre for Pharmacometrics,
    MCOPS, MAHE

Workshop Description:

Bioequivalence (BE) evaluation is a critical step in drug development, yet traditional Non-Compartmental Analysis (NCA) often struggles with complex scenarios—such as sparse sampling, high inter-individual variability, and long-acting formulations.

This one-day workshop introduces Model-Based Bioequivalence (MBBE) using Pumas. Participants will move beyond the limitations of NCA, learning to utilize population pharmacokinetic models to handle missing data, optimize study designs, and differentiate between subject and residual variability. The course will also cover Virtual Bioequivalence
(VBE), teaching attendees how to perform simulations to ensure robust regulatory compliance, determine optimal sample sizes, and control Type 1 error rates.

Category
Registration Fee (per participant)
Students/Trainees
₹ 1500
Academicians
₹ 2000
Industry Professionals
₹ 3000

International delegates please contact organizers for registration: icop.india@sophas.net

Abstract Submission

 

Submit your abstracts for the ICoP India 2026 Conference.

Submission Window: August 4 – December 15, 2025

Please ensure your abstract aligns with the conference theme.

Abstract Submission Guidelines:

  • Original research work from following areas will be accepted

    1. Quantitative approaches in drug development

    2. PKPD models

    3. Clinical Pharmacometrics

    4. Methodological studies

    5. PBPK modeling for drug drug interactions

    6. PBBM absorption modeling

    7. Bioequivalence risk assessments using modeling approaches

    8. Biostudy waivers using novel modeling approaches

    Author:
    Please provide information on all the authors with their affiliations and email id for corresponding author. The presenting author should be underlined.
    The same author list will appear in the abstract book.

    Language:
    All abstracts must be in English

    Abstract Body:
    The work published in previous national or international meetings or journals will not be accepted. The abstract should contain the statement on hypothesis or objective, the methods used, results and conclusion. The font of text should be Times New Roman with 12 font size. Abstract text should be typed single-spaced and with maximum 350 words. Type the text as one paragraph. All references included in the abstract should be numbered and accompanied by the full citation, including authors names, title, journal name, volume, number, inclusive paging, and year of publication.

Abstract Acceptance Notification: within 30 working days after the submission deadline.

In case of any unforeseen delay, we will inform you at the earliest..

Call for Satellite Workshops

The Organizing Committee of ICoP India 2026 invites proposals for satellite workshops to take place alongside the main conference as pre- and post-workshops.

Table of Contents
Information
Event Dates
28th and 31st Jan 2026
Location
Academic Venues
Topics of Interest
To be aligned with the conference theme
Proposal Deadline
October 20, 2025

Submission Guidelines: Include workshop title, abstract (≤ 500 words), format, target audience, and brief CVs of speakers.

Contact: Connect with SOPHAS

Selected workshops are tentatively scheduled to be announced by October 30, 2025.

Help shape this year’s conference by delivering a hands-on, engaging session for our diverse community!

BECOME A

Sponsor

ICoP India 2026

We invite organizations to partner with us as sponsors for ICoP India 2026, a premier international conference focused on Quantitative Approaches in Drug Development. Sponsorship offers your brand:

  • High visibility across sessions and outreach platforms
  • Direct engagement with academia, industry, and regulatory leaders

An opportunity to support innovation in pharmaceutical science.

Conference Details
  • Dates: 29–30 January 2026
  • Venue: Fortune Valley View, Manipal
Sponsorship Opportunities

Explore our sponsorship packages and benefits in the brochure below:

To Apply

Submit your expression of interest through the form:

Sponsors Of ICoP India 2026

Platinum Partner

Accommodation Options:

1. Official (Paid) Hostel Accommodation

Accommodation is limited. After registration, eligible registrants will be contacted for hostel arrangements on a first-come, first-served basis. ICoP India 2026 provides accommodation only in institute-allotted hostel facilities (not hotel rooms). Accommodation is limited and will be allotted on a first-come, first-served basis, subject to availability and your preferences.

After registration, eligible participants will be contacted for hostel arrangements, and applicable charges will be communicated upon confirmation.

2. Hotel Suggestions

The conference venue (Fortune Valley View, Manipal) offers rooms for direct booking. 

Additionally, we have compiled a list of recommended hotels nearby for your convenience.
Click the button below to view the hotel suggestions and plan your stay:

Travel Information: Getting to ICoP India 2026

1. How to Reach the Venue

The conference will be held at Fortune Valley View, Manipal

Manipal is well-connected by air, rail, and road. The nearest airport is Mangalore International Airport, while Udupi is the closest railway station. Frequent buses also link Manipal to major cities like Bangalore, Goa, Hyderabad, and Mumbai, making it easily accessible from across India and abroad.

  • Nearest Railway Station: Udupi (UD) – approx. 5 km from Manipal From Udupi station, taxis and buses are readily available for the short ride to Manipal.   

2. Explore Around the Venue

Manipal is located in Karnataka, South India, perched at an altitude of approximately 100 meters and only about 10 kilometers inland from the Arabian Sea. Surrounded by the lush Western Ghats on one side and the coastline on the other, this picturesque university town offers a unique blend of green hills, tropical waterways, and a warm cultural ambiance.

Make the most of your visit! Nearby places to explore:

Note: Please check the visiting hours and opening days of each attraction before planning your visit.

Need Help? Contact Us

For any queries regarding registration, payment, accommodation, or the conference schedule, feel free to reach out to us:

Email: icop.india@sophas.net
Website: sophas.net

We’ll be happy to assist you!

What Past Participants Say

Hear from those who’ve been part of the ICoP experience:

[Name], [Designation], [Institution/Organization]
"ICOP provided the perfect platform to engage with experts across academia and industry. The discussions were insightful, and the workshops were truly hands-on."
[Name], [Designation], [Institution/Organization]
"The diversity of sessions and the networking opportunities were exceptional. I returned with practical skills and collaborations."
[Name], [Designation], [Institution/Organization]
"As a student, I felt incredibly welcome. The speakers were approachable, and the exposure to real-world case studies was invaluable."
[Name], [Designation], [Institution/Organization]
"A thoughtfully curated event — from the pre-conference workshops to the scientific sessions, everything ran smoothly and left an impact."

Join us at ICOP India 2026 and be part of a growing global community advancing quantitative approaches in drug development.

Registration & Fees

1. How do I register for the conference?

Registrations will remain open until 10 January 2026, subject to availability of slots. Early registration is encouraged, especially for workshops and accommodation, as these are allocated on a first-come-first-served basis.

The main conference registration fee includes:

  • Access to all sessions on 29–30 January 2026
  • Conference kit and program schedule booklet
  • Participation certificate
  • Lunch and tea on conference days

     

Workshop registration includes access to the selected workshop, materials (if any), and refreshments.

Accommodation & Venue

1. Where is the conference venue located?

The conference will be held at: Fortune Valley View, Manipal Udupi District, Karnataka, India View on Google Maps

Accommodation: Participants need to make their own arrangements.

We don’t handle hotel bookings, but we’re happy to share a few suggestions to help you plan your stay.

The conference venue, Fortune Valley View, Manipal, offers rooms for direct booking.

Here are some recommended options:

Click Here

Travel Information

1. What is the nearest airport and railway station?

Nearest Airport: Mangalore International Airport (IXE) – approx. 65 km

Nearest Railway Station: Udupi Railway Station – approx. 6 km

We do not provide airport transfers, but local taxis and app-based cab services (e.g., Ola, Uber) are available. Assistance with directions will be provided upon request.

Abstracts & Presentations

1. When is the deadline for abstract submissions?

The deadline for abstract submissions is 30 November 2025.

Abstract review results will be communicated via email within 10 working days after the submission deadline.

In case of any unforeseen delay, we will inform you at the earliest.

Detailed presentation guidelines (format, timing, poster dimensions, etc.) will be shared with selected presenters along with the acceptance notification. Please ensure your content aligns with the conference theme and scientific scope.

Certificates & Payments

1. Will I receive a certificate of attendance?

Yes. All participants who attend the conference (virtually or in person) will receive a Certificate of Attendance. Participants of workshops will receive additional certification.

Payments can be made via Razorpay using the links provided in the registration form. 

Registration Fees: Non-refundable, but transferable to another participant from the same organization with prior approval.

 

ICOP 2025 Abstract Submission Guidelines

Original research work from following areas will be accepted

  1. Quantitative approaches in drug development
  2. PKPD models
  3. Clinical Pharmacometrics
  4. Methodological studies
  5. PBPK modeling for drug drug interactions
  6. PBBM absorption modeling
  7. Bioequivalence risk assessments using modeling approaches
  8. Biostudy waivers using novel modeling approaches

 

Author:

Please provide information on all the authors with their affiliations and email id for corresponding author. The presenting author should be underlined. The same author list will appear in the abstract book.

Language:

All abstracts must be in English

Abstract Body:

The work published in previous national or international meetings or journals will not be accepted. The abstract should contain the statement on hypothesis or objective, the methods used, results and conclusion. The font of text should be Times New Roman with 12 font size. Abstract text should be typed single-spaced and with maximum 300 words. Type the text as one paragraph. All references included in the abstract should be numbered and accompanied by the full citation, including authors names, title, journal name, volume, number, inclusive paging, and year of publication

Abstract Submission Form

Personal Information
Contact Information